ProKidney Q2 EPS $(0.13) Beats $(0.15) Estimate, Sales $221.000K
Benzinga Newsdesk 1 year ago
EarningsEarnings BeatsNews
ProKidney (NASDAQ:PROK) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.15) by 13.33 percent. This is a 18.75 percent increase over losses of $(0.16) per share from the
ProKidney (NASDAQ:PROK) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.15) by 13.33 percent. This is a 18.75 percent increase over losses of $(0.16) per share from the same period last year. The company reported $221.000 thousand in sales this quarter.